Citadel Advisors’s Jasper Therapeutics JSPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Buy |
410,444
+35,274
| +9% | +$196K | ﹤0.01% | 2571 |
|
|
2025
Q1 | $1.61M | Sell |
375,170
-48,440
| -11% | -$208K | ﹤0.01% | 2791 |
|
|
2024
Q4 | $9.06M | Buy |
423,610
+282,046
| +199% | +$6.03M | ﹤0.01% | 1390 |
|
|
2024
Q3 | $2.66M | Buy |
+141,564
| New | +$2.66M | ﹤0.01% | 2258 |
|
|
2024
Q2 | – | Sell |
-16,210
| Closed | -$476K | – | 6402 |
|
|
2024
Q1 | $476K | Sell |
16,210
-2,906
| -15% | -$85.3K | ﹤0.01% | 3970 |
|
|
2023
Q4 | $151K | Buy |
19,116
+11,283
| +144% | +$89K | ﹤0.01% | 4728 |
|
|
2023
Q3 | $54.8K | Sell |
7,833
-134,769
| -95% | -$943K | ﹤0.01% | 5050 |
|
|
2023
Q2 | $1.95M | Sell |
142,602
-258,702
| -64% | -$3.54M | ﹤0.01% | 2438 |
|
|
2023
Q1 | $7.26M | Buy |
401,304
+87,800
| +28% | +$1.59M | ﹤0.01% | 1533 |
|
|
2022
Q4 | $1.49M | Buy |
313,504
+3,302
| +1% | +$15.7K | ﹤0.01% | 2837 |
|
|
2022
Q3 | $2.45M | Buy |
310,202
+12,902
| +4% | +$102K | ﹤0.01% | 2539 |
|
|
2022
Q2 | $5.74M | Sell |
297,300
-2,158
| -0.7% | -$41.7K | ﹤0.01% | 1731 |
|
|
2022
Q1 | $10.6M | Sell |
299,458
-5,158
| -2% | -$183K | ﹤0.01% | 1360 |
|
|
2021
Q4 | $22.8M | Buy |
304,616
+4,112
| +1% | +$307K | ﹤0.01% | 863 |
|
|
2021
Q3 | $29.2M | Buy |
300,504
+291,870
| +3,380% | +$28.4M | 0.01% | 690 |
|
|
2021
Q2 | $859K | Sell |
8,634
-1,114
| -11% | -$111K | ﹤0.01% | 4166 |
|
|
2021
Q1 | $969K | Buy |
+9,748
| New | +$969K | ﹤0.01% | 3956 |
|